Locoregional Apo2L/TRAIL eradicates intracranial human malignant glioma xenografts in athymic mice in the absence of neurotoxicity

Biochemical and Biophysical Research Communications

Volumn 265, Issue 2, 1999, Pages 479-483

  Roth, Wilfried ^a   Isenmann, Stefan ^a   Naumann, Ulrike ^a   Kügler, Sebastian ^a   Bähr, Mathias ^a   Dichgans, Johannes ^a   Ashkenazi, Avi ^b   Weller, Michael ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b GENENTECH INC   (United States)

Author keywords

Apo2L (TRAIL); Apoptosis; Death ligands; In vivo; Malignant glioma

Indexed keywords

APO 2 LIGAND; FAS LIGAND; LIGAND; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; INTRATUMORAL DRUG ADMINISTRATION; MOUSE; NEUROTOXICITY; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TUMOR VOLUME; TUMOR XENOGRAFT;

ANIMALIA; MUS MUSCULUS;

EID: 0033584823     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1999.1693     Document Type: Article

References (24)

1. Weller M., Rieger J., Grimmel C., Van Meir E. G., De Tribolet N., Krajewski S., Reed J. C., Von Deimling A., Dichgans J. Int. J. Cancer. 79:1998;640-644.
2. Yount G. L., Haas-Kogan D. A., Levine K. S., Aldape K. D., Israel M. A. Cancer Res. 58:1998;3819-3825.
3. Weller M., Kleihues P., Dichgans J., Ohgaki H. Brain Pathol. 8:1998;285-293.
4. Roth W., Fontana A., Trepel M., Reed J. C., Dichgans J., Weller M. Cancer Immunol. Immunother. 44:1997;55-63.
5. Rieger J., Naumann U., Glaser T., Ashkenazi A., Weller M. FEBS Lett. 427:1998;124-128.
6. Ogasawara J., Watanabe-Fukunaga R., Adachi M., Matsuzawa A., Kasugai T., Kitamura Y., Itoh N., Suda T., Nagata S. Nature. 364:1993;806-809.
7. Walczak H., Miller R. E., Ariail K., Gliniak B., Griffith T. S., Kubin M., Chin W., Jones J., Woodward A., Le T., Smith C., Smolak P., Goodwin R. G., Rauch C. T., Schuh J. C., Lynch D. H. Nat. Med. 5:1999;157-163.
8. Ashkenazi A., Pai R. C., Fong S., Leung S., Lawrence D. A., Marsters S. A., Blackie C., Chang L., McMurtrey A., Hebert A., DeForge L., Koumenis I. L., Lewis D., Harris L., Bussiere J., Koeppen H., Shahrokh Z., Schwall R. H. J. Clin. Invest. 104:1999;155-162.
9. Ashkenazi A., Dixit V. M. Science. 281:1998;1305-1308.
10. Griffith T. S., Wiley S. R., Kubin M. Z., Sedger L. M., Maliszewski C. R., Fanger N. A. J. Exp. Med. 189:1999;1343-1353.
11. Mariani S. M., Matiba B., Armandola E. A., Krammer P. H. J. Cell. Biol. 137:1997;221-229.
12. Wiley S. R., Schooley K., Smolak P. J., Din W. S., Huang C. P., Nicholl J. K., Sutherland G. R., Smith T. D., Rauch C., Smith C. A., Goodwin R. G. Immunity. 3:1995;673-682.
13. Pan G., Ni J., Wei Y. F., Yu G., Gentz R., Dixit V. M. Science. 277:1997;815-818.
14. Pitti R. M., Marsters S. A., Ruppert S., Donahue C. J., Moore A., Ashkenazi A. J. Biol. Chem. 271:1996;12687-12690.
15. Rieger J., Ohgaki H., Kleihues P., Weller M. Acta Neuropathol. 97:1999;1-4.
16. Sheridan J. P., Marsters S. A., Pitti R. M., Gurney A., Skubatch M., Baldwin D., Ramakrishnan L., Gray C. L., Baker K., Wood W. I., Goddard A. D., Godowski P., Ashkenazi A. Science. 277:1997;818-821.
17. Marsters S. A., Sheridan J. P., Pitti R. M., Huang A., Skubatch M., Baldwin D., Yuan J., Gurney A., Goddard A. D., Godowski P., Ashkenazi A. Curr. Biol. 7:1997;1003-1006.
18. Isenmann S., Bähr M. Exp. Neurol. 147:1997;28-36.
19. Perry V. H., Hume D. A., Gordon S. Neuroscience. 15:1985;313-326.
20. Isenmann S., Stoll G., Schroeter M., Krajewski S., Reed J. C., Bähr M. Brain Pathol. 8:1998;49-63.
21. Keane M. M., Ettenberg S. A., Nau M. M., Russell E. K., Lipkowitz S. Cancer Res. 59:1999;734-741.
22. Roth W., Wagenknecht B., Grimmel C., Dichgans J., Weller M. Br. J. Cancer. 77:1998;404-411.
23. Weller M., Frei K., Groscurth P., Krammer P. H., Yonekawa Y., Fontana A. J. Clin. Invest. 94:1994;954-964.
24. Roth W., Wagenknecht B., Dichgans J., Weller M. J. Neuroimmunol. 87:1998;121-129.